Drug Metabolism and Pharmacokinetics : Impact Factor & More
eISSN: 1880-0920pISSN: 1347-4367
Share this on:
Key Metrics
CiteScore 
4.5
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.79
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drug Metabolism and Pharmacokinetics
Drug Metabolism and Pharmacokinetics Journal Specifications
| Overview | |
| Publisher | JAPANESE SOC STUDY XENOBIOTICS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Metabolism and Pharmacokinetics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drug Metabolism and Pharmacokinetics
Current Status of Prediction of IL-6 Mediated Cytochrome P450 Activity Modulation using In Vitro Data and PBPK Modeling
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Role of Metabolites in Drug-Drug Interactions
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Future Directions in Drug-Drug Interaction Evaluations: Industry Perspective on the ICH M12 Guidance
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8.
- 1 Dec 2025
- Drug metabolism and pharmacokinetics
Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Positive Implications of PBPK Platform Qualification for Predicting Drug–Drug Interactions: Taking on Cracks Only to See Bigger Gaps!
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Current Status of Prediction of IL-6 Mediated Cytochrome P450 Activity Modulation using In Vitro Data and PBPK Modeling
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Role of Metabolites in Drug-Drug Interactions
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Future Directions in Drug-Drug Interaction Evaluations: Industry Perspective on the ICH M12 Guidance
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8.
- 1 Dec 2025
- Drug metabolism and pharmacokinetics
Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
Positive Implications of PBPK Platform Qualification for Predicting Drug–Drug Interactions: Taking on Cracks Only to See Bigger Gaps!
- 1 Dec 2025
- Drug Metabolism and Pharmacokinetics
FAQs on Drug Metabolism and Pharmacokinetics
How long has Drug Metabolism and Pharmacokinetics been actively publishing? 
What is the publishing frequency of Drug Metabolism and Pharmacokinetics?
How many articles did Drug Metabolism and Pharmacokinetics publish last year?
What is the eISSN & pISSN for Drug Metabolism and Pharmacokinetics?
What is Citescore for Drug Metabolism and Pharmacokinetics?
What is SNIP score for Drug Metabolism and Pharmacokinetics?
What is the SJR for Drug Metabolism and Pharmacokinetics?
Who is the publisher of Drug Metabolism and Pharmacokinetics?
